About this trial
This study investigates how different types of fasting affect cell health, specifically focusing on how mitochondria (the energy-producing parts of cells) are cleared and renewed. While standard intermittent fasting allows water intake, Ramadan dry fasting involves total restriction of both food and fluids from dawn to sunset.
Researchers want to see if the combined effects of fluid restriction and natural daily body rhythms during Ramadan trigger a stronger cellular cleanup process (called mitophagy) compared to standard 16:8 water-permitted fasting. The study will look at how these fasting habits change blood markers related to mitochondrial DNA and metabolic health across a 30-day period. This research will help determine if dry fasting offers distinct biological benefits for cellular renewal.
Eligibility criteria
Qualifiers
Age 18-50 years
BMI 18.5-30.0 kg/m²[cite: 1]
Non-smoker for at least 12 months[cite: 1]
No chronic disease requiring regular prescription medication[cite: 1]
Disqualifiers
Established type 1 or type 2 diabetes (HbA1c 6.5% or higher or pharmacological antidiabetic therapy)[cite: 1]
Severe gastrointestinal, cardiovascular, hepatic, or renal disease (eGFR less than 60 mL/min/1.73m²)[cite: 1]
Active cancer or chemotherapy within five years[cite: 1]
Use of metformin, statins, or exogenous antioxidant supplements (vitamins C, E, NAC, CoQ10) within 30 days of screening[cite: 1]
Trial design
Treatments tested in this trial
- Ramadan Intermittent Dry Fasting (Sawm)
- 16:8 Time-Restricted Feeding (TRF)